相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Orexin deficiency modulates cognitive flexibility in a sex-dependent manner
Archana Durairaja et al.
GENES BRAIN AND BEHAVIOR (2021)
Increased plasma orexin-A concentrations are associated with the non-motor symptoms in Parkinson's disease patients
Shen Huang et al.
NEUROSCIENCE LETTERS (2021)
Changes of Hypocretin (Orexin) System in Schizophrenia: From Plasma to Brain
Jing Lu et al.
SCHIZOPHRENIA BULLETIN (2021)
The contribution of orexins to sex differences in the stress response
Laura A. Grafe et al.
BRAIN RESEARCH (2020)
Orexin A in adolescents with anxiety disorders
Omer Faruk Akca et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2020)
A higher body mass index in Chinese inpatients with chronic schizophrenia is associated with elevated plasma orexin-A levels and fewer negative symptoms
Zhiwei Liu et al.
NORDIC JOURNAL OF PSYCHIATRY (2020)
Orexin-A Levels in Relation to the Risk of Metabolic Syndrome in Patients with Schizophrenia Taking Antipsychotics
Po-Yu Chen et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2019)
HPLC analysis of CSF hypocretin-1 in type 1 and 2 narcolepsy
Noriaki Sakai et al.
SCIENTIFIC REPORTS (2019)
Considerably Lower Levels of Hypocretin-1 in Cerebrospinal Fluid Is Revealed by a Novel Mass Spectrometry Method Compared with Standard Radioimmunoassay
Kjetil Bardsen et al.
ANALYTICAL CHEMISTRY (2019)
New revolution in the assessment of cerebrospinal fluid orexin-A: Enzyme-linked immunosorbent assay!
Claudio Liguori et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2019)
Reduced plasma orexin-A levels in patients with bipolar disorder
Shoko Tsuchimine et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2019)
Current Concepts and Treatments of Schizophrenia
Piotr Stepnicki et al.
MOLECULES (2018)
Measurement of cerebrospinal fluid orexin-A (hypocretin-1) by enzyme-linked immunosorbent assay: A comparison with radioimmunoassay
Taisuke Ono et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2018)
The Orexin System and Hypertension
Michael J. Huber et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2018)
Orexin research: patent news from 2016
Christoph Boss et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
New Targets for Schizophrenia Treatment beyond the Dopamine Hypothesis
Albert C. Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis
Carsten Hjorthoj et al.
LANCET PSYCHIATRY (2017)
Improving Current Treatments for Schizophrenia
Nadja P. Maric et al.
DRUG DEVELOPMENT RESEARCH (2016)
Diurnal neurobiological alterations after exposure to clozapine in first-episode schizophrenia patients
Hong-Qiang Sun et al.
PSYCHONEUROENDOCRINOLOGY (2016)
Changes in orexin (hypocretin) neuronal expression with normal aging in the human hypothalamus
Nicholas J. Hunt et al.
NEUROBIOLOGY OF AGING (2015)
Elevated plasma orexin A levels in a subgroup of patients with schizophrenia associated with fewer negative and disorganized symptoms
Yi-Ling Chien et al.
PSYCHONEUROENDOCRINOLOGY (2015)
The Hypocretin System and Psychiatric Disorders
Fabio Pizza et al.
CURRENT PSYCHIATRY REPORTS (2014)
Orexin: A potential role in the process of obstructive sleep apnea
Wei Wang et al.
PEPTIDES (2013)
The physiological role of orexin/hypocretin neurons in the regulation of sleep/wakefulness and neuroendocrine functions
Ayumu Inutsuka et al.
Frontiers in Endocrinology (2013)
OREXIN SIGNALING IN THE PARAVENTRICULAR THALAMIC NUCLEUS MODULATES MESOLIMBIC DOPAMINE AND HEDONIC FEEDING IN THE RAT
D. L. Choi et al.
NEUROSCIENCE (2012)
Convergent actions of orexin/hypocretin and CRF on dopamine neurons: Emerging players in addiction
Stephanie L. Borgland et al.
BRAIN RESEARCH (2010)
Orexin-A and respiration in a rat model of smoke-induced chronic obstructive pulmonary disease
Zi-Bing Liu et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2010)
Plasma orexin A, ghrelin, cholecystokinin, visfatin, leptin and agouti-related protein levels during 6-week olanzapine treatment in first-episode male patients with psychosis
Cengiz Basoglu et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2010)
The environment and schizophrenia
Jim van Os et al.
NATURE (2010)
Orexin/hypocretin in psychiatric disorders: present state of knowledge and future potential
Stephanie L. Borgland et al.
NEUROPSYCHOPHARMACOLOGY (2010)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Alessandro Liberati et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Dopamine depletion of the prefrontal cortex induces dendritic spine loss: Reversal by atypical antipsychotic drug treatment
Hui-Dong Wang et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Schizophrenia, hypocretin (Orexin), and the thalamocortical activating system
Evelyn K. Lambe et al.
SCHIZOPHRENIA BULLETIN (2007)
The orexins/hypocretins and schizophrenia
Ariel Y. Deutch et al.
SCHIZOPHRENIA BULLETIN (2007)
A randomized, double-blind, placebo-controlled trial on modafinil for negative symptoms in schizophrenia
Joseph M. Pierre et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Double-blind, placebo-controlled study of modafinil for fatigue and cognition in schizophrenia patients treated with psychotropic medications
S Sevy et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
A systematic review of the prevalence of schizophrenia
S Saha et al.
PLOS MEDICINE (2005)
Controlling the risk of spurious findings from meta-regression
JPT Higgins et al.
STATISTICS IN MEDICINE (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Assessing publication bias in meta-analysis
KL Soeken et al.
NURSING RESEARCH (2003)
The intralaminar and midline nuclei of the thalamus. Anatomical and functional evidence for participation in processes of arousal and awareness
YD Van der Werf et al.
BRAIN RESEARCH REVIEWS (2002)
Decreased plasma orexin-A levels in obese individuals
JA Adam et al.
INTERNATIONAL JOURNAL OF OBESITY (2002)
Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia
LA Glantz et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)